- ►ascopubs.org [PDF] MA Smith, DR Parkinson, BD Cheson, MA … - Journal of clinical oncology, 1992 - jco.ascopubs.org Purpose: Recent reports of the dramatic antitumor effect of all-trans retinoic
acid (RA) in patients with acute promyelocytic leukemia (APL) have generated
renewed enthusiasm for clinical studies of retinoids for oncologic ... Cited by 424 - Related articles - All 7 versions
HW Chen, DP Sandler, JA Taylor, DA Bell, DL … - The lancet, 1996 - Elsevier Background The glutathione S-transferases (GST) mediate exposure to various
cytotoxic and genotoxic agents, including those associated with increased risk
of the myelodysplastic syndromes (MDS). Both GST M1 (GSTM1) and GST theta 1 ... Cited by 218 - Related articles - All 6 versions
- ►hematologylibrary.org [PDF] JE Anderson, FR Appelbaum, LD Fisher, G … - Blood, 1993 - bloodjournal.hematologylibrary.org . reserved Hematology; all rights Copyright 2007 by The American Society of
Suite 200, Washington DC 20036. semimonthly by the American Society of
Hematology, 1900 M St, NW, Blood (print ISSN 0006-4971, online ISSN ... Cited by 185 - Related articles - BL Direct - All 7 versions
- ►grg-bs.it [PDF] L Balducci - European Journal of Cancer, 2000 - Elsevier 1. Who is old? Currently, 70 years of age may be considered the lower limit of
senescence because the majority of age-related changes occur after this age.
Individual estimates of life expectancy and functional reserve may be ... Cited by 142 - Related articles - BL Direct - All 21 versions
- ►hematologylibrary.org - Free from Publisher TJ Nevill, HC Fung, JD Shepherd, DE Horsman … - Blood, 1998 - bloodjournal.hematologylibrary.org Allogeneic bone marrow transplantation (BMT) is the only curative therapy
available for patients with myelodysplastic syndrome (MDS). In an attempt to
identify prognostic factors influencing outcome, we collected data ... Cited by 132 - Related articles - BL Direct - All 5 versions
- ►bloodjournal.org [PDF] RS Stein, RI Abels, SB Krantz - Blood, 1991 - Am Soc Hematology . reserved Hematology; all rights Copyright 2007 by The American Society of
Suite 200, Washington DC 20036. semimonthly by the American Society of
Hematology, 1900 M St, NW, Blood (print ISSN 0006-4971, online ISSN ... Cited by 125 - Related articles - All 4 versions
EH Rose, RI Abels, RA Nelson, DM … - British journal of Haematology, 1995 - interscience.wiley.com One hundred and sixteen (116) anaemic patients with myelodysplastic syndromes
(MDS) were treated with recombinant human erythropoietin (r-HuEpo) in an
openlabel, multicentre, compassionate treatment trial; 100 patients ... Cited by 93 - Related articles - BL Direct - All 3 versions
- ►jcojournal.org [PDF] JE Anderson, FR Appelbaum, G Schoch, T … - Journal of Clinical Oncology, 1996 - jcojournal.org Purpose: To determine if an intensive preparative regimen of busulfan (BU),
cyclophosphamide (CY), and total-body irradiation (TBI) could improve outcome
after marrow transplantation for advanced morphology my- elodysplasia ( ... Cited by 89 - Related articles - BL Direct - All 7 versions
- ►hematologylibrary.org [PDF] M Andreeff, R Stone, J Michaeli, CW Young, … - Blood, 1992 - bloodjournal.hematologylibrary.org . reserved Hematology; all rights Copyright 2007 by The American Society of
Suite 200, Washington DC 20036. semimonthly by the American Society of
Hematology, 1900 M St, NW, Blood (print ISSN 0006-4971, online ISSN ... Cited by 71 - Related articles - BL Direct - All 4 versions
- ►hematologylibrary.org - Free from Publisher JA Thompson, DG Gilliland, JT Prchal, JM … - Blood, 2000 - bloodjournal.hematologylibrary.org From the Division of Oncology, University of Washington, Seattle, WA;
Hematology/Oncology Research, Howard Hughes Medical Institute, Brigham and
Women's Hospital, Harvard Medical School, Boston, MA; Division of ... Cited by 62 - Related articles - BL Direct - All 5 versions
